Market Tracker

04/17 6:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.73
Data as of Apr 17
 +0.04 / +2.37%
Today’s Change
1.11
Today|||52-Week Range
3.18
+24.46%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.69
Today’s open1.69
Day’s range1.65 - 1.74
Volume1,307,914
Average volume (3 months)4,478,772
Market cap$333.5M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)+12.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+42.34%
P/E ratioNM
Price/Sales7.72
Price/Book11.44

Competitors

 Today’s
change
Today’s
% change
DRTXDurata Therapeutics ...-0.11-0.86%
RGLSRegulus Therapeutics...-0.02-0.29%
ATNMActinium Pharmaceuti...+0.11+0.94%
DRNADicerna Pharmaceutic...+0.11+0.67%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateJuly 15, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$21.7M
Annual profit (last year)-$29.8M
Net profit margin-137.34%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts